DUBLIN/California/USA, 26.04.2019. ZEISS Medical Technology Segment today launched the first dual-speed Swept-Source OCT/OCTA that will now scan at 200kHz, in addition to 100kHz, providing doctors a deeper and more detailed view into the retina enabling visualization options for various diseases. The
PLEX Elite 2.0 enables faster, deeper, and higher resolution imaging of the eye, elevating ophthalmic imaging and clinical research to a new level. Varying speeds can be applied to different disease states in the eye and expand possibilities of research.
The launch of PLEX Elite 2.0 is a major step forward in the evolution of Swept-Source OCT/OCTA, said Jim Mazzo, Global President of Ophthalmic Devices at Carl Zeiss Meditec. It is another example of our continued commitment to clinical research and building technology to benefit patients.
At the core of this accelerated development of research with PLEX Elite is the Advanced Imaging Network, a unique collaboration of practitioners with the mission of advancing research and innovation in the fields of retina and glaucoma. This one-of-a-kind innovation engine brings together renowned clinicians and scientists from around the world using a cloud-based software platform to interact and collaborate in real time, all with a unified goal to advance the future of eye care.
With the PLEX Elite 2.0's deeper and more detailed view into the retina, doctors can fully image conditions such as posterior staphylomas, retinal detachments, high myopia, and choroidal tumors. This evolution provides faster scans to visualize from the retinal vitreous interface all the way down to the choroid to assess highly curved myopic eyes in an unprecedented way.
Collaboration with leading experts continues to be at the heart of our innovation process, said Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec AG. This new level of collaboration has the potential to open new frontiers of discovery in research, and to accelerate the development of innovations to benefit patients today and in the future.
Since its launch in 2016, the Advanced Imaging Network has grown significantly and expanded beyond the retina to glaucoma and optic nerve diseases and promises to expand further. The network plans to continue their collaboration and enable researchers to further experiment on the clinical utility of Swept Source technology in Ophthalmology.
During ARVO, ZEISS will also showcase the PLEX Elite along with the company's other flagship devices at Booth 1317. For more information, visit
https://www.zeiss.com/meditec/int/c/zeiss-at-arvo-2019.html.
$DAM-94DAF8484550ECCEC12583E70047CD9F
$DAM-F5996F37793334A2C12583E70047D79D
Sebastian Frericks
Director Investor Relations
Carl Zeiss Meditec AG
Phone: +49 3641 220-116
Fax:
investors.meditec@zeiss.com
Laurie Ferguson
Head of Global Communications Ophthalmic Devices
Phone: +1 925 719 7825
Email: press.meditec@zeiss.com
Brief profile
Carl Zeiss Meditec AG (ISIN: DE 0005313704), which is listed on the MDAX and TecDAX of the German stock exchange, is one of the world's leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With approximately 3,050 employees worldwide, the Group generated revenue of 1,280.9m in fiscal year 2017/18 (to 30 September). The Group's head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Companys presence in these rapidly developing economies. Around 41 percent of Carl Zeiss Meditec AG's shares are in free float. The remaining approx. 59 percent are held by Carl Zeiss AG, one of the world's leading groups in the optical and optoelectronic industries.
For more information visit our website at: www.zeiss.com/med
Number: 0037-2019-ENG OP
Number of Words: 440
Number of Characters: 3123
More from Carl Zeiss
24/07/2019
JENA/Germany, 24.07.2019. ZEISS introduces new capabilities for ZEISS ion beam m...
16/07/2019
JENA/Germany, 16.07.2019. Carl Zeiss Meditec (ISIN: DE0005313704) has achieved r...
15/07/2019
DUBLIN/CA/USA, OBERKOCHEN/Germany, 15.07.2019. The internationally leading optic...
10/07/2019
OBERKOCHEN/Germany, 10.07.2019. Even though 50 years have passed since the first...
20/06/2019
OBERKOCHEN/Germany, BRAUNSCHWEIG/Germany, 19.06.2019. ZEISS has confirmed that the acquisition of GOM, a leading provider of hardware and software for automated...
23/05/2019
OBERKOCHEN/Germany, 23.05.2019. ZEISS has launched a new, integrated 360-degree communications campaign for the ZEISS Batis lens family to describe what the ZEI...
22/05/2019
OBERKOCHEN/Germany, BERLIN/Germany, 21.05.2019. President & CEO of the ZEISS Group, Prof. Kaschke: "The top ranking in the 2019 Public Value Atlas demonstrat...
15/05/2019
OBERKOCHEN/Germany, LOS ANGELES/USA, 15.05.2019. For over 100 years, ZEISS has provided cinematography lenses to filmmakers at all levels. From their headquarte...
07/05/2019
JENA/Germany, 07.05.2019. Smart Microscopy from ZEISS is a new concept for the routine digital documentation of microscopic samples. The microscopes ZEISS Axiol...
07/05/2019
OBERKOCHEN/Germany, 07.05.2019.
- Industrial Metrology successful tha...
07/05/2019
OBERKOCHEN/Germany, STUTTGART/Germany, 06.05.2019. With ZEISS eSolutions, ZEISS is offering metrology and inspection solutions that provide seamless quality ass...
07/05/2019
STUTTGART/Germany, 06.05.2019. ZEISS will present its comprehensive ZEISS X-ray ...
07/05/2019
JENA/Germany, 06.05.2019. In the first half of fiscal year 2018/19 Carl Zeiss...
07/05/2019
OBERKOCHEN/Germany, STUTTGART/Germany, 06.05.2019. In keeping with the theme "Co...
04/05/2019
JENA/Germany, 04.05.2019. ZEISS Medical Technology Segment will announce several...
30/04/2019
OBERKOCHEN/Germany, 30.04.2019. With the release of the ZEISS Ventum 2.8/21, ZEI...
24/04/2019
OBERKOCHEN/Germany, 24.04.2019. With the ZEISS Otus 1.4/100, ZEISS is expanding ...
13/04/2019
OBERKOCHEN/Germany, 11.03.2019. The free ZEISS Hunting app now comes with new features that make hunting that much easier: the new hunting grounds manager allow...
11/04/2019
JENA/Germany, 11.04.2019. The proven ZEISS Celldiscoverer 7 is a fully integrate...
11/04/2019
OBERKOCHEN/Germany, BRAUNSCHWEIG/Germany, 11.04.2019. ZEISS is expanding the ind...
09/04/2019
OBERKOCHEN/Germany, 09.04.2019. American photographer Rory Doyle won the fourth ZEISS Photography Award with his photo series Delta Hill Riders'. Photograp...
09/04/2019
JENA/Germany, 09.04.2019. The new Multiplex mode for ZEISS Airyscan 2 delivers m...
03/04/2019
JENA/Germany, Heilbronn/Germany, 02.04.2019. Heilbronn. A ZEISS UNIVERSARIUM Model IX projects a realistic night sky onto the museums Science Dome.
Spread out ...
02/04/2019
HANNOVER/Germany, OBERKOCHEN/Germany, 01.04.2019. The new 5G mobile standard wil...
29/03/2019
HANNOVER/Germany, JENA/Germany, 28.03.2019. Uploading real-time production da...
27/03/2019
JENA/Germany, 04.03.2019. ZEISS ZEN Connect software module is now available for...
14/03/2019
JENA/Germany, 14.03.2019. ZEISS Semiconductor Mask Solutions has been recognized...
25/02/2019
JENA/Germany, 25.02.2019. ZEISS ZEN core is a powerful software suite for micros...
23/02/2019
JENA/Germany, KOLKATA/India, 22.02.2019. With its 23-meter dome and 360 seats, t...
14/02/2019
OBERKOCHEN/Germany, PLEASANTON/California/USA , 23.01.2019. New submicron and...
14/02/2019
JENA/Germany, BENSHEIM/Germany, PUNE/India, 13.02.2019. 36 million people aro...
12/02/2019
JENA/Germany, 11.02.2019. In the first three months of fiscal year 2018/19 Ca...
07/02/2019
JENA/Germany, San Francisco/USA, 04.02.2019. For the first time ever, a technology developed by ZEISS has made it possible to utilize transparent glass or plast...
01/02/2019
OBERKOCHEN/Germany, TOKYO/Japan, VELDHOVEN/The Netherlands, 23.01.2019. Nikon Corporation ( Nikon ) (TYO: 7731), ASML Holding N.V. ( ASML ) (NASDAQ: ASML) and C...
24/01/2019
JENA/Germany, 23.01.2019. ZEISS introduces two new advanced models of the ZEISS Xradia Versa family: The ZEISS Xradia 610 & 620 Versa X-ray microscopes excel th...
14/01/2019
JENA/Germany, 14.01.2019. Carl Zeiss Meditec (ISIN: DE0005313704) has achieved r...
21/12/2018
OBERKOCHEN/Germany, BOZEMAN/Montana/USA, 20.12.2018.
Bridger Photonics, Inc., ...
18/12/2018
STUTTGART/Germany, 18.12.2018.
The ZEISS Group is continuing its growth trajectory. In fiscal year 2017/18 (ended on 30 September 2018), the company achieved ...
17/12/2018
OBERKOCHEN/Germany; Lyon, Michigan/USA, 17.12.2018. With the official groundbrea...
07/12/2018
JENA/Germany, 07.12.2018. Carl Zeiss Meditec AG increased its revenue fu...
04/12/2018
JENA/Germany, 04.12.2018. ZEISS is introducing ZEISS Elyra 7 with Lattice SIM, a new flexible platform for fast and gentle 3D superresolution. Lattice SIM expan...
22/11/2018
OBERKOCHEN/Germany, 22.11.2018. ZEISS and the World Photography Organisation invite photographers worldwide to enter the 2019 ZEISS Photography Award. Now in it...
19/11/2018
JENA/Germany, CAPE TOWN/South Africa, 19.11.2018. ZEISS today announces its bigg...
06/11/2018
JENA/Germany, SAN DIEGO/California/USA, 05.11.2018. At the Annual Meeting of the...
29/10/2018
JENA/Germany, MUNICH/Germany, 29.10.2018. ZEISS and arivis have now expanded and...
27/10/2018
CHICAGO/USA, 27.10.2018.
The Annual Meeting of the American Academy of Ophthal...
25/10/2018
JENA/Germany, 23.10.2018.
Carl Zeiss Meditec today announced it has entered in...
DUBLIN/California/USA, 26.04.2019. ZEISS Medical Technology Segment today launched the first dual-speed Swept-Source OCT/OCTA that will now scan at 200kHz, in addition to 100kHz, providing doctors a deeper and more detailed view into the retina enabling visualization options for various diseases. The PLEX Elite 2.0 enables faster, deeper, and higher resolution imaging of the eye, elevating ophthalmic imaging and clinical research to a new level. Varying speeds can be applied to different disease states in the eye and expand possibilities of research.
